Determinants for Antitumor and Protumor Effects of Programmed Cell Death

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Cytotoxic therapies induce programmed cell death, releasing danger signals that modulate the tumor microenvironment.
• These signals can stimulate anti-tumor immunity or, conversely, attract immunosuppressive cells, promoting tumor progression.
• The precise impact of cell death on tumor fate remains largely unknown due to tumor subversion of these processes.

Purpose of the Study:

• To explore the understudied aspects of cell death's contribution to tumor elimination or progression.
• To investigate how tumor genetics, epigenetics, and oncogenic factors influence immunogenic cell death.
• To provide insights for future research on the complex immunologic effects of cell death in diverse tumor contexts.

Main Methods:

• This perspective synthesizes current knowledge on cell death and the tumor microenvironment.
• It analyzes the mechanisms by which tumors subvert immunogenic cell death.
• It discusses the role of genetic and epigenetic factors in modulating these responses.

Main Results:

• Cancer cell death can elicit both anti-tumor and pro-tumor immune responses.
• Tumor-associated factors significantly influence whether cell death promotes elimination or progression.
• Subversion of immunogenic cell death by tumors is a key mechanism of immune evasion.

Conclusions:

• Understanding the dual role of cell death in cancer is critical for developing effective immunotherapies.
• Future research must consider tumor-specific genetic and microenvironmental factors when assessing cell death outcomes.
• Targeting the modulation of cell death pathways holds promise for enhancing anti-cancer immunity.